Megaphone Eyewire headlines are now available as a weekly podcast! Listen Now

Now Playing

Eyewire TV December 11, 2024 thumbnail

Introduction

Positive Phase 3 Results for MELT-300 Sedation Tablet thumbnail

Positive Phase 3 Results for MELT-300 Sedation Tablet

First Patient Dosed in Phase 3 Trial Evaluating Duravyu for Wet AMD thumbnail

First Patient Dosed in Phase 3 Trial Evaluating Duravyu for Wet AMD

Outlook Receives Positive Reimbursement Decision in UK for Lytenava thumbnail

Outlook Receives Positive Reimbursement Decision in UK for Lytenava


Previous EyewireTV Episodes